Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Molecular Pharmacology|March 1, 1992
Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infectionJ K Sastry, P N Nehete, S Khan, et al.
Cancer Research|December 1, 1994
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivoV Grégoire, N T Van, L C Stephens, et al.
Leukemia|January 1, 1992
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991M J Keating, E Estey, H Kantarjian, et al.
Pediatric Dermatology|September 13, 2011
Neonatal linear immunoglobulin a bullous dermatosis: a rare presentationMeena R Julapalli, Kirra L Brandon, Cecilia M Rosales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulationS R Patel, V Gandhi, J Jenkins, et al.
Leukemia|August 1, 1994
Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinosideH M Ghaddar, W Plunkett, H M Kantarjian, et al.
Leukemia|September 10, 2011
MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AMLB Z Carter, D H Mak, Y Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisisS J Iacoboni, W Plunkett, H M Kantarjian, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Molecular Pharmacology|March 1, 1992
Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infectionJ K Sastry, P N Nehete, S Khan, et al.
Cancer Research|December 1, 1994
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivoV Grégoire, N T Van, L C Stephens, et al.
Leukemia|January 1, 1992
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991M J Keating, E Estey, H Kantarjian, et al.
Pediatric Dermatology|September 13, 2011
Neonatal linear immunoglobulin a bullous dermatosis: a rare presentationMeena R Julapalli, Kirra L Brandon, Cecilia M Rosales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulationS R Patel, V Gandhi, J Jenkins, et al.
Leukemia|August 1, 1994
Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinosideH M Ghaddar, W Plunkett, H M Kantarjian, et al.
Leukemia|September 10, 2011
MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AMLB Z Carter, D H Mak, Y Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisisS J Iacoboni, W Plunkett, H M Kantarjian, et al.
Pageof 25